VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2021

May 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2021-05-01

Reporting Person: Garber Alan M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-01	Stock Option (Right to Buy)	$217.20	A	6067	Acquired	2031-04-30	Common Stock (6067)	Direct

Footnotes

F1: Fully vested.